Japan Regenerative Medicine Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Japan Regenerative Medicine General Information

Description

Developer of regenerative medicine catering to pediatric congenital heart disease patients.

Contact Information

Website
www.j-rm.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Life Innovation Center, 3-25-22 Tonomachi
  • Kawasaki-ku
  • Kawasaki, Kanagawa 210-0821
  • Japan
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • Life Innovation Center, 3-25-22 Tonomachi
  • Kawasaki-ku
  • Kawasaki, Kanagawa 210-0821
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Japan Regenerative Medicine Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Japan Regenerative Medicine‘s full profile, request access.

Request a free trial

Japan Regenerative Medicine Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Japan Regenerative Medicine‘s full profile, request access.

Request a free trial

Japan Regenerative Medicine FAQs

  • When was Japan Regenerative Medicine founded?

    Japan Regenerative Medicine was founded in 2013.

  • Where is Japan Regenerative Medicine headquartered?

    Japan Regenerative Medicine is headquartered in Kawasaki, Japan.

  • What industry is Japan Regenerative Medicine in?

    Japan Regenerative Medicine’s primary industry is Biotechnology.

  • Is Japan Regenerative Medicine a private or public company?

    Japan Regenerative Medicine is a Private company.

  • What is Japan Regenerative Medicine’s current revenue?

    The current revenue for Japan Regenerative Medicine is .

  • Who are Japan Regenerative Medicine’s investors?

    Noritsu Koki has invested in Japan Regenerative Medicine.

  • When was Japan Regenerative Medicine acquired?

    Japan Regenerative Medicine was acquired on 04-Apr-2022.

  • Who acquired Japan Regenerative Medicine?

    Japan Regenerative Medicine was acquired by Metcela.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process